U.S. Clinical Laboratory Services Market (2025 - 2033) Size, Share & Trends Analysis Report By Test Type (Genetic Testing, Cytology Testing, Clinical Chemistry), By Service Provider (Hospital-Based Laboratories, Stand-Alone Laboratories), By Application, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                   1.2. Segment Definitions
                       1.2.1. Test Type
                       1.2.2. Service Provider
                       1.2.3. Application
                       1.2.4. Estimates and forecasts timeline
                   1.3. Research Methodology
                   1.4. Information Procurement
                       1.4.1. Purchased database
                       1.4.2. GVR’s internal database
                       1.4.3. Secondary sources
                       1.4.4. Primary research
                       1.4.5. Details of primary research
                           1.4.5.1. Data for primary interviews in U.S.
                   1.5. Information or Data Analysis
                       1.5.1. Data analysis models
                   1.6. Market Formulation & Validation
                   1.7. Model Details
                       1.7.1. Commodity flow analysis (Model 1)
                       1.7.2. Approach 1: Commodity flow approach
                       1.7.3. Volume price analysis (Model 2)
                       1.7.4. Approach 2: Volume price analysis
                   1.8. List of Secondary Sources
                   1.9. List of Primary Sources
                   1.10. Objectives
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                       2.2.1. Test Type outlook
                       2.2.2. Service Provider outlook
                       2.2.3. Application outlook
                   2.3. Competitive Insights
Chapter 3. U.S. Clinical Laboratory Services Market Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook
                   3.2. Market Dynamics
                       3.2.1. Market driver analysis
                           3.2.1.1. Technological advancements in the field of clinical testing
                           3.2.1.2. Growing prevalence of target diseases coupled with rising demand for early disease diagnostic tests
                           3.2.1.3. Introduction of novel solutions
                           3.2.1.4. Outbreak of COIVD-19 pandemic
                       3.2.2. Market restraint analysis
                           3.2.2.1. Presence of stringent regulatory framework
                   3.3. U.S. Clinical laboratory services market Analysis Tools
                       3.3.1. Industry Analysis - Porter’s
                           3.3.1.1. Supplier power
                           3.3.1.2. Buyer power
                           3.3.1.3. Substitution threat
                           3.3.1.4. Threat of new entrant
                           3.3.1.5. Competitive rivalry
                       3.3.2. PESTEL Analysis
                           3.3.2.1. Political landscape
                           3.3.2.2. Technological landscape
                           3.3.2.3. Economic landscape
Chapter 4. U.S. Clinical laboratory services market: Test Type Estimates & Trend Analysis
                   4.1. Test Type Market Share, 2024 & 2033
                   4.2. Segment Dashboard
                   4.3. U.S. Clinical laboratory services market by Test Type Outlook
                   4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
                       4.4.1. Genetic Testing
                           4.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                       4.4.2. Clinical Chemistry
                           4.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                           4.4.2.2. Routine Chemistry Testing Market estimates and forecasts 2021 to 2033 (USD Million)
                           4.4.2.3. Therapeutic Drug Monitoring Testing Market estimates and forecasts 2021 to 2033 (USD Million)
                           4.4.2.4. Endocrinology Chemistry Testing Market estimates and forecasts 2021 to 2033 (USD Million)
                           4.4.2.5. Specialized Chemistry Testing Market estimates and forecasts 2021 to 2033 (USD Million)
                           4.4.2.6. Other Clinical Chemistry Testing Market estimates and forecasts 2021 to 2033 (USD Million)
                       4.4.3. Medical Microbiology Testing
                           4.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                           4.4.3.2. Infectious Disease Testing Market estimates and forecasts 2021 to 2033 (USD Million)
                           4.4.3.3. Transplant Diagnostic Testing Market estimates and forecasts 2021 to 2033 (USD Million)
                           4.4.3.4. Other Microbiology Testing Market estimates and forecasts 2021 to 2033 (USD Million)
                       4.4.4. Hematology Testing
                           4.4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                       4.4.5. Immunology Testing
                           4.4.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                       4.4.6. Cytology Testing
                           4.4.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                       4.4.7. Drug of Abuse Testing
                           4.4.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                       4.4.8 Other Esoteric Tests
                   4.4.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. U.S. Clinical Laboratory Services Market: Service Provider Estimates & Trend Analysis
                   5.1. Service Provider Market Share, 2024 & 2033
                   5.2. Segment Dashboard
                   5.3. U.S. Clinical laboratory services market by Service Provider Outlook
                   5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
                       5.4.1. Hospital-Based Laboratories
                           5.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                       5.4.2. Stand-Alone Laboratories
                           5.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                       5.4.3. Clinic-Based Laboratories
                           5.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. U.S. Clinical Laboratory Services Market: Application Estimates & Trend Analysis
                   6.1. Application Market Share, 2024 & 2033
                   6.2. Segment Dashboard
                   6.3. U.S. Clinical laboratory services market by Application Outlook
                   6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
                       6.4.1. Bioanalytical & Lab Chemistry Services
                           6.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                       6.4.2. Toxicology Testing Services
                           6.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                       6.4.3. Cell & Gene Therapy Related Services
                           6.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                       6.4.4. Preclinical & Clinical Trial Related Services
                           6.4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                       6.4.5. Drug Discovery & Development Related Services
                           6.4.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                       6.4.6. Others
                           6.4.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Competitive Landscape
                   7.1. Recent Developments & Impact Analysis, By Key Market Participants
                   7.2. Company/Competition Categorization
                   7.3. Vendor Landscape
                       7.3.1. List of key distributors and channel partners
                       7.3.2. Key customers
                       7.3.3. Key company market share analysis, 2024
                       7.3.4. LABORATORY CORPORATION OF AMERICA HOLDINGS (LABCORP)
                           7.3.4.1. Company overview
                           7.3.4.2. Financial performance
                           7.3.4.3. Product benchmarking
                           7.3.4.4. Strategic initiatives
                       7.3.5. Eurofins Scientific SE
                           7.3.5.1. Company overview
                           7.3.5.2. Financial performance
                           7.3.5.3. Product benchmarking
                           7.3.5.4. Strategic initiatives
                       7.3.6. QIAGEN NV
                           7.3.6.1. Company overview
                           7.3.6.2. Financial performance
                           7.3.6.3. Product benchmarking
                           7.3.6.4. Strategic initiatives
                       7.3.7. Quest Diagnostics Incorporated
                           7.3.7.1. Company overview
                           7.3.7.2. Financial performance
                           7.3.7.3. Product benchmarking
                           7.3.7.4. Strategic initiatives
                       7.3.8. OPKO HEALTH, INC.
                           7.3.8.1. Company overview
                           7.3.8.2. Financial performance
                           7.3.8.3. Product benchmarking
                           7.3.8.4. Strategic initiatives
                       7.3.9. Charles River Laboratories International, Inc.
                           7.3.9.1. Company overview
                           7.3.9.2. Financial performance
                           7.3.9.3. Product benchmarking
                           7.3.9.4. Strategic initiatives
                       7.3.10. ARUP LABORATORIES
                           7.3.10.1. Company overview
                           7.3.10.2. Financial performance
                           7.3.10.3. Product benchmarking
                           7.3.10.4. Strategic initiatives
                       7.3.11. Sonic Healthcare
                           7.3.11.1. Company overview
                           7.3.11.2. Financial performance
                           7.3.11.3. Product benchmarking
                           7.3.11.4. Strategic initiatives
                       7.3.12. Neogenomics Laboratories
                           7.3.12.1. Company overview
                           7.3.12.2. Financial performance
                           7.3.12.3. Product benchmarking
                           7.3.12.4. Strategic initiatives
                       7.3.13. Fresenius Medical Care
                           7.3.13.1. Company overview
                           7.3.13.2. Financial performance
                           7.3.13.3. Product benchmarking
                           7.3.13.4. Strategic initiatives
                       7.3.14. Siemens Medical Solutions USA, Inc.
                           7.3.14.1. Company overview
                           7.3.14.2. Financial performance
                           7.3.14.3. Product benchmarking
                           7.3.14.4. Strategic initiatives
                       7.3.15. SYNLAB International GmbH
                           7.3.15.1. Company overview
                           7.3.15.2. Financial performance
                           7.3.15.3. Product benchmarking
                           7.3.15.4. Strategic initiatives
                       7.3.16. Mayo Clinic Laboratories
                           7.3.16.1. Company overview
                           7.3.16.2. Financial performance
                           7.3.16.3. Product benchmarking
                           7.3.16.4. Strategic initiatives
                       7.3.17. Unilabs
                           7.3.17.1. Company overview
                           7.3.17.2. Financial performance
                           7.3.17.3. Product benchmarking
                           7.3.17.4. Strategic initiatives

List of Tables

Table 1 List of abbreviation
Table 2 U.S. Clinical laboratory services market, by test type, 2021 - 2033 (USD Million)
Table 3 U.S. Clinical laboratory services market, by service provider, 2021 - 2033 (USD Million)
Table 4 U.S. Clinical laboratory services market, by application, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in U.S.
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 U.S. clinical laboratory services market: market outlook
Fig. 10 U.S. clinical laboratory services competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 U.S. Clinical laboratory services market driver impact
Fig. 16 U.S. Clinical laboratory services market restraint impact
Fig. 17 U.S. Clinical laboratory services market strategic initiatives analysis
Fig. 18 U.S. Clinical laboratory services market: Test Type movement analysis
Fig. 19 U.S. Clinical laboratory services market: Test Type outlook and key takeaways
Fig. 20 Genetic Testing market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 21 Clinical chemistry market estimates and forecast 2021 - 2033 (USD Million)
Fig. 22 Routine chemistry testing market estimates and forecast 2021 - 2033 (USD Million)
Fig. 23 Therapeutic drug monitoring testing market estimates and forecast 2021 - 2033 (USD Million)
Fig. 24 Endocrinology chemistry testing market estimates and forecast 2021 - 2033 (USD Million)
Fig. 25 Specialized chemistry testing market estimates and forecast 2021 - 2033 (USD Million)
Fig. 26 Other clinical chemistry testing market estimates and forecast 2021 - 2033 (USD Million)
Fig. 27 Medical microbiology testing market estimates and forecast 2021 - 2033 (USD Million)
Fig. 28 Infectious disease testing market estimates and forecast 2021 - 2033 (USD Million)
Fig. 29 Transplant diagnostic testing market estimates and forecast 2021 - 2033 (USD Million)
Fig. 30 Other microbiology testing market estimates and forecast 2021 - 2033 (USD Million)
Fig. 31 Hematology testing market estimates and forecast 2021 - 2033 (USD Million)
Fig. 32 Immunology testing market estimates and forecast 2021 - 2033 (USD Million)
Fig. 33 Cytology testing market estimates and forecast 2021 - 2033 (USD Million)
Fig. 34 Drug of abuse testing market estimates and forecast 2021 - 2033 (USD Million)
Fig. 35 Other esoteric tests market estimates and forecast 2021 - 2033 (USD Million)
Fig. 36 U.S. Clinical laboratory services market: Service Provider movement Analysis
Fig. 37 U.S. Clinical laboratory services market: Service Provider outlook and key takeaways
Fig. 38 Hospital-based laboratories market estimates and forecast 2021 - 2033 (USD Million)
Fig. 39 Stand-alone laboratories market estimates and forecasts 2021 - 2033 (USD Million)
Fig. 40 Clinic-based laboratories market estimates and forecasts 2021 - 2033 (USD Million)
Fig. 41 U.S. Clinical laboratory services market: application movement analysis
Fig. 42 U.S. Clinical laboratory services market: application outlook and key takeaways
Fig. 43 Bioanalytical & lab chemistry services market estimates and forecast 2021 - 2033 (USD Million)
Fig. 44 Toxicology testing services market estimates and forecasts 2021 - 2033 (USD Million)
Fig. 45 Cell & gene therapy related services market estimates and forecast 2021 - 2033 (USD Million)
Fig. 46 Preclinical & clinical trial related services market estimates and forecasts 2021 - 2033 (USD Million)
Fig. 47 Drug discovery & development related services market estimates and forecast 2021 - 2033 (USD Million)
Fig. 48 Other U.S. Clinical laboratory services market estimates and forecasts 2021 - 2033 (USD Million)
Fig. 49 U.S. Clinical laboratory services market share and leading players
Fig. 50 U.S. market share and leading players
Fig. 51 U.S. SWOT
Fig. 52 U.S. market estimates and forecast 2021 - 2033 (USD Million)
Fig. 53 Market share of key market players - U.S. Clinical laboratory services market